Recursion Pharmaceuticals Appoints Najat Khan as Chief Commercial Officer and Head of R&D
Position
Chief Commercial Officer
Company
Recursion Pharmaceuticals
Salt Lake CityBiotechnologyHealthcareHealth CareArtificial IntelligenceTherapeuticsPharmaceuticalDescription
Recursion Pharmaceuticals has hired Najat Khan, Ph.D., as chief commercial officer and head of R&D. With her extensive experience as the former chief data science officer and head of strategy and portfolio at Johnson & Johnson, Khan's vision and passion for transforming drug discovery and development align with Recursion's goals and position in the field.
Quick answer
Recursion Pharmaceuticals Appoints Najat Khan as Chief Commercial Officer and Head of R&D (April 19, 2024). Recursion Pharmaceuticals is based in Salt Lake City, Utah, United States.
- Who is the new Chief Commercial Officer at Recursion Pharmaceuticals?
- Recursion Pharmaceuticals named Najat Khan Chief Commercial Officer, announced April 19, 2024.
- What did Recursion Pharmaceuticals announce on April 19, 2024?
- Recursion Pharmaceuticals has hired Najat Khan, Ph.D., as chief commercial officer and head of R&D. With her extensive experience as the former chief data science officer and head of strategy and portfolio at Johnson & Johnson, Khan's vision and passion for transforming drug discovery and development align with Recursion's goals and position in the field.
- What does Recursion Pharmaceuticals do?
- Recursion Pharmaceuticals, Inc. is a biotechnology company that leverages advanced technology to discover and develop potential new drugs.
- Where is Recursion Pharmaceuticals based?
- Recursion Pharmaceuticals is based in Salt Lake City, Utah, United States.
- Which similar companies made leadership changes around the same time?
- EyePoint, Inc. (May 9, 2024), Madrigal Pharmaceuticals (March 11, 2024), Crinetics Pharmaceuticals (May 30, 2024) and Verastem Oncology (April 18, 2024) also announced leadership changes within 45 days of Recursion Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- EyePoint Pharmaceuticals, Inc. Appoints Isabelle Lefebvre as Chief Regulatory Officer (May 9, 2024)
- Madrigal Pharmaceuticals Appoints Mardi C. Dier as Senior Vice President and Chief Financial Officer (March 11, 2024)
- Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D. as Senior Vice President of Medical Affairs (May 30, 2024)
- Verastem Oncology Appoints John Hayslip, M.D. as Chief Medical Officer (April 18, 2024)
- Athira Pharma Appoints Javier San Martin as Chief Medical Officer (April 15, 2024)
- Terns Pharmaceuticals, Inc. Appoints Melita Sun Jung as Chief Business Officer (April 10, 2024)
Who to call at Recursion Pharmaceuticals, and when
A new leader at Recursion Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Recursion Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Recursion Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Recursion Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Recursion Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Recursion Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.